ALBANY, N.Y., Jan. 04, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Joseph DeVivo, President and Chief Executive Officer, is scheduled to present at the 34th Annual J.P. Morgan Global Healthcare Conference on Wednesday, January 13, 2016, at 5:30 p.m. EST. The conference will be held at the Westin St. Francis in San Francisco, Ca.
A live audio and/or webcast and subsequent archived replay of AngioDynamics' presentation may be accessed via the investor relations section of the Company's website under "Events & Presentations" at http://investors.angiodynamics.com/events.cfm. The replay will be available for 90 days after the event.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access,
surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a
subsidiary.
Company Contact:
AngioDynamics, Inc.Caitlin Stefanik
(518) 795-1418
cstefanik@angiodynamics.com
Investor Relations Contacts:
EVC Group, Inc.Chris Dailey
(646) 445-4801
cdailey@evcgroup.com
Media Contact:
EVC Group, Inc.Dave Schemelia
(646) 201-5431
dave@evcgroup.com
Source:
AngioDynamics
News Provided by Acquire Media